Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Hepatology. 2023 Jan 3;77(5):1527–1539. doi: 10.1097/HEP.0000000000000027

TABLE 3.

Postoperative data

n = 1087, n (%) Missing data
90 d mortality 31 (2.9) 0
90 d morbidity 376 (34.6) 0
Major morbidity (Clavien-Dindo ≥ III) 150 (13.8) 2
Comprehensive complication index 22.6 (20.9–37.1) 5
Postoperative ascites 107 (9.8) 0
Liver failure 35 (3.2) 0
Bile leak 55 (5.0) 0
Sepsis 29 (2.6) 0
Superficial surgical site infection 23 (2.3) 0
Pleural effusion 57 (5.2) 0
Pneumonia 43 (4.0) 0
Deep vein thrombosis/pulmonary embolism 14 (1.3) 0
Myocardial infarction 10 (0.9) 0
Atrial fibrillation 31 (2.9) 0
Urinary tract infection 21 (1.9) 0
Acute kidney injury 31 (2.9) 0
Hemorrhage 24 (2.2) 0
Other 114 (10.5) 0
POD 1 bilirubin (mg/dL) 1.1 (0.7–1.58) 448
POD 1 INR 1.2 (1.12–1.36) 418
POD 1 platelets (103/mm3) 173 (133–223) 329
POD 3 bilirubin (mg/dL) 1.2 (0.8–1.75) 460
POD 3 INR 1.2 (1.1–1.36) 474
POD 3 platelets (103/mm3) 161 (121–207) 372
POD 5 bilirubin (mg/dl) 1 (0.7–1.6) 652
POD 5 INR 1.2 (1.1–1.3) 687
POD 5 platelets (103/mm3) 184 (141–243) 552
Hospital stay (d) 6 (5–9) 5
Readmission 81 (8.5) 136
R1 resection 95 (8.8) 12

Note: Continuous data were expressed as median (25th–75th percentile). Abbreviations: INR, international normalized ratio; POD, postoperative day.